Literature DB >> 1805194

Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol.

R E Royer1, R G Mills, L M Deck, G J Mertz, D L Vander Jagt.   

Abstract

Gossypol (I) and its derivatives gossylic nitrile-1,1'-diacetate (II), gossylic iminolactone (III) and gossylic lactone (IV) inhibit the replication of human immunodeficiency virus type 1 in vitro in the order III greater than I greater than II,IV, indicating that derivatives of gossypol can retain antiviral activities. All of the derivatives are less cytotoxic than gossypol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805194     DOI: 10.1016/1043-6618(91)90045-y

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  4 in total

Review 1.  Small-molecule inhibitors of human LDH5.

Authors:  Carlotta Granchi; Ilaria Paterni; Reshma Rani; Filippo Minutolo
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

2.  Synthesis of benzyl substituted naphthalenes from benzylidene tetralones.

Authors:  Lorraine M Deck; Quintino Mgani; Andrea Martinez; Alice Martinic; Lisa J Whalen; David L Vander Jagt; Robert E Royer
Journal:  Tetrahedron Lett       Date:  2012-01-25       Impact factor: 2.415

3.  Developing gossypol derivatives with enhanced antitumor activity.

Authors:  X S Liang; A J Rogers; C L Webber; T J Ormsby; M E Tiritan; S A Matlin; C C Benz
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

4.  The interaction of PVP complexes of gossypol and its derivatives with an artificial membrane lipid matrix.

Authors:  Maksim Ionov; Ilnora Tukfatullina; Bakhtiyar Salakhutdinov; Nina Baram; Maria Bryszewska; Takhir Aripov
Journal:  Cell Mol Biol Lett       Date:  2009-11-20       Impact factor: 5.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.